Effects of Recombinant Human Glutamic Acid Decarboxylase on the Progression of Type 1 Diabetes in New Onset Subjects

Clinical trial NCT00529399 · COMPLETED

Trial details

NCT number

NCT00529399

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2009-02-01

Primary completion

2012-05-01

Enrollment

145

View on ClinicalTrials.gov